Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Sciele Pharma

Sciele Pharma, Inc. (NASDAQ:SCRX), formerly known as First Horizon Pharmaceutical Corp., is a pharmaceutical company specializing in sales, marketing, and the development of branded prescription products focused on Cardiovascular/Metabolic and Women’s Health. The Company’s cardiovascular/metabolic products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina, and type 2 diabetes, and its Women’s Health products are designed to improve the health and well-being of women and their babies. Headquartered in Atlanta, Georgia, and founded in 1992, Sciele Pharma employs more than 700 people, including approximately 525 sales representatives. The Company’s success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform – an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity and Teamwork.


Contact Details:
Five Concourse Parkway Suite 1800
Atlanta
Georgia
30328
United States of America
Tel:(800) 461-3696
Fax:
Email:ir@sciele.com
WWW:

www.sciele.com/




Loading...

Press Releases on Sciele Pharma:

BioPortfolio Logo
Video: National Association of School Nurses Launches 'Back to School' Campaign to Educate Parents, Community About Head Lice 14th September, 2009 National Association of School Nurses
SILVER SPRING, Md., Sept. 14 /PRNewswire/ -- The National Association of School Nurses (NASN) announced today the kickoff of S.C.R.A.T.C.H. (School and Community Resources to Avoid and Take Control of
Omega-3 Fatty Acids Key to Fetal Development - Possible Mercury Contamination Concerns in Some Fish Oil Avoided With Plant-based DHA in PreNexa(R) Prenatal Vitamins 25th June, 2009 Upsher-Smith Laboratories, Inc.
MAPLE GROVE, Minn., June 25 /PRNewswire/ -- Leading experts specifically recommend Docosahexaenoic acid (DHA) as a key omega-3 fatty acid for prenatal development(1, 2, 3). DHA, derived from plants or
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication 23rd April, 2009 Addrenex Pharmaceuticals, Inc.
Study shows Clonicel(R) and stimulants combined provide greater improvement in symptoms than stimulants alone DURHAM, N.C., April 23 /PRNewswire/ -- Addrenex Pharmaceuticals, Inc. today announced
First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 3rd December, 2008 Upsher-Smith Laboratories, Inc.
MINNEAPOLIS, Dec. 3 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced its plans to market PreNexa(TM), the first and only single gel capsule prenatal vitamin with the most plant-based
Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415 23rd October, 2008 Addrenex Pharmaceuticals
DURHAM, N.C., Oct. 23 /PRNewswire/ -- Addrenex Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved its Investigational New Drug Application (IND) for ADX415, a

BioNews Results for Sciele Pharma:

Penis Spray Makes Men Last Longer
WebMD:  Nov 20 2009 8:28PM Matching: sciele pharma
Medical News: Pivotal Study For PSD502--The First Potential Treatment For Premature Ejaculation
BioFind:  Nov 20 2009 12:57PM Matching: sciele pharma
Data from second positive pivotal study of PSD502 for treatment of PE presented
News-Medical.Net:  Nov 20 2009 6:00AM Matching: sciele pharma
Sciele Pharma, a Shionogi Company, Presents Pivotal Study for PSD502 The First Potential Treatment for Premature Ejaculation At the Sexual Medicine
Yahoo! Canada:  Nov 19 2009 2:36PM Matching: sciele pharma
Pivotal Study for PSD502--The First Potential Treatment for Premature Ejaculation
Newswise:  Nov 19 2009 4:15PM Matching: sciele pharma
Promote your company here: BioNewsCast - Press Release Distribution

View more Sciele Pharma news.

Sciele Pharma Clinical Trials:

A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

Sciele Pharma (SCRX) Financial information Links from Barchart

SCRX Quote from from Barchart.com
SCRX Chart from from Barchart.com
SCRX Profile from from Barchart.com
SCRX Opinion from from Barchart.com

View more Sciele Pharma finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 648 times since April 2007, the link to the organisation's website has been followed 115 times

Recent Search Terms used to find this page: Sciele Pharma Inc. fax phone | sciele pharma logo | sciele pharma logo | sciele lo | sciele logo | sciele | sciele pharma jobs | sciele logo | sciele pharma phone number in atlanta ga | addrenex adhd april 23 BioPortfolio | .

Search for more companies in Atlanta

Search for more companies in Georgia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sciele Pharma

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.